Tyche Industries

26
Strong Sell
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE443B01012
  • NSEID:
  • BSEID: 532384
INR
105.65
0.2 (0.19%)
BSENSE

Feb 03

BSE+NSE Vol: 2.81 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is -5.81% vs -7.79% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is -10.75% vs -21.69% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is 0.00% vs 36.36% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 1.34% vs -13.61% in Mar 2024

Compare Profit and Loss Results of Tyche Industries
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
65.00
302.00
-237.00
-78.48%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
65.00
302.00
-237.00
-78.48%
Expenditure (Ex Depriciation)
Stock Adjustments
-2.00
-7.00
5.00
71.43%
Raw Materials Consumed
27.00
164.00
-137.00
-83.54%
Power & Fuel Cost
4.00
8.00
-4.00
-50.00%
Employee Cost
9.00
61.00
-52.00
-85.25%
Operating Expenses
7.00
10.00
-3.00
-30.00%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
2.00
12.00
-10.00
-83.33%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
0.00
0.00
0%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
54.00
272.00
-218.00
-80.15%
Operating Profit (PBDIT) excl Other Income
11.00
30.00
-19.00
-63.33%
Other Income
7.00
2.00
5.00
250.00%
Operating Profit (PBDIT)
18.00
32.00
-14.00
-43.75%
Interest
0.00
17.00
-17.00
-100.00%
Profit before Depriciation and Tax
18.00
15.00
3.00
20.00%
Depreciation
1.00
9.00
-8.00
-88.89%
Profit Before Taxation & Exceptional Items
16.00
5.00
11.00
220.00%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
16.00
5.00
11.00
220.00%
Provision for Tax
4.00
-2.00
6.00
300.00%
Profit After Tax
12.00
7.00
5.00
71.43%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
108.00
42.00
66.00
157.14%
Profit Available for appropriations
121.00
50.00
71.00
142.00%
Appropriations
121.00
50.00
71.00
142.00%
Equity Dividend (%)
30%
12%
18.00
Earnings Per Share
12.2
4.89
7.31
149.49%
Profit And Loss - Net Sales
Net Sales 65.47 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -5.81% vs -7.79% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.29 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -10.75% vs -21.69% in Mar 2024

Profit And Loss - Interest
Interest 0.00 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 0.00% vs 36.36% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 12.41 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 1.34% vs -13.61% in Mar 2024